Author Question: The client receives chemotherapy as therapy for cancer. The physician orders epoetin alfa (Procrit) ... (Read 68 times)

jho37 · **on:** Jul 23, 2018

The client receives chemotherapy as therapy for cancer. The physician orders epoetin alfa (Procrit) subcutaneously. The client asks the nurse if this drug is also chemotherapy. What is the best response by the nurse?

1. No, but it works with your chemotherapy to make it more effective.
2. No, this drug helps to counteract the nausea and vomiting caused by your chemotherapy.
3. No, it will stimulate your immune system to help you battle the cancer.
4. No, this drug will help prevent anemia that can be caused by your chemotherapy.

Question 2

The client receives filgrastim (Neupogen). He asks the nurse, That is such a funny name; where do you suppose it comes from? What is the best response by the nurse?

1. It comes from the interleukins it stimulates; this one stimulates neuocytes.
2. It comes from the blood cell it stimulates; this one stimulates neutrophils.
3. It comes from the stem cells it stimulates, such as filgrastims.
4. It is a complicated process; the drug companies are secretive about it.

bbburns21 · **Reply #1 on:** Jul 23, 2018

Answer to Question 1

Correct Answer: 4
Rationale: Epoetin alfa (Procrit) is prescribed to treat anemia associated with chemotherapy; it does not make the chemotherapy more effective.

Answer to Question 2

Correct Answer: 2
Rationale 1: There aren't any interleukins named neuocytes.
Rationale 2: Colony-stimulating factors (CSFs) are named according to the types of blood cells that they stimulate. Granulocyte colony-stimulating factor (G-CSF) increases the production of neutrophils, the most common type of granulocyte.
Rationale 3: There aren't any stem cells named filgrastims.
Rationale 4: Naming of drugs is not a complicated process.